Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. HealBerry
WARNING LETTER
•HealBerry•August 1, 2025

HealBerry – FDA Warning Letter, Aug 1, 2025

Record Details

On September 9, 2025, the U.S. Food and Drug Administration (FDA) issued a warning letter to HealBerry, a company based in Beverly Hills, California, following a review of its website in August 2025. The agency’s investigation focused on the marketing of compounded drug products, specifically semaglutide. The FDA identified significant violations of the Federal Food, Drug, and Cosmetic Act (FDCA) regarding how these products are advertised. The primary issue cited is the use of false or misleading claims, such as stating that their compounded semaglutide contains the "same active ingredient as Ozempic and Wegovy." The FDA clarified that such claims are deceptive because compounded drugs are not FDA-approved, and implying they are identical to approved brand-name medications constitutes misbranding. Under the regulatory framework, selling misbranded drugs in interstate commerce is illegal. HealBerry is required to take immediate corrective actions, including ceasing the use of the misleading language. The company must conduct a thorough review of its operations to ensure compliance with federal law and prevent future violations. A formal written response is required within 15 working days, outlining the specific steps taken to address the FDA"s concerns. Failure to comply may lead to legal enforcement actions, such as product seizures or injunctions.

Company
HealBerry
Inspection date
August 1, 2025
Product type
drugs
Office
Center for Drug Evaluation and Research
Person
  • George Tidmarsh (Director)
View Company Profile

ID · 6709a31a-8634-4335-b2cb-5e9fd04509d5

Violation Codes10
21 U.S.C. 331(c)21 U.S.C. 352(a)FD&C Act 201(p)FD&C Act 502(bb)21 U.S.C. 352(bb)FD&C Act 201(g)(1)FD&C Act 502(a)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)FD&C Act 301(a)

Full citation text and observation details available on the Dashboard.

Other documents for HealBerry
  • WARNING_LETTER - 2025-08-31August 31, 2025

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore HealBerry
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.